“Teva’s CEO chose to give conservative guidance”
After giving a positive return in 2022, and in 2023 to date, Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) ...
After giving a positive return in 2022, and in 2023 to date, Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.